BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21677141)

  • 21. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments.
    Zhang JG; Czabotar PE; Policheni AN; Caminschi I; Wan SS; Kitsoulis S; Tullett KM; Robin AY; Brammananth R; van Delft MF; Lu J; O'Reilly LA; Josefsson EC; Kile BT; Chin WJ; Mintern JD; Olshina MA; Wong W; Baum J; Wright MD; Huang DC; Mohandas N; Coppel RL; Colman PM; Nicola NA; Shortman K; Lahoud MH
    Immunity; 2012 Apr; 36(4):646-57. PubMed ID: 22483802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
    Joffre OP; Sancho D; Zelenay S; Keller AM; Reis e Sousa C
    Eur J Immunol; 2010 May; 40(5):1255-65. PubMed ID: 20333625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response.
    Fossum E; Tesfaye DY; Bobic S; Gudjonsson A; Braathen R; Lahoud MH; Caminschi I; Bogen B
    J Immunol; 2020 Aug; 205(3):661-673. PubMed ID: 32591401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
    J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.
    Caminschi I; Proietto AI; Ahmet F; Kitsoulis S; Shin Teh J; Lo JC; Rizzitelli A; Wu L; Vremec D; van Dommelen SL; Campbell IK; Maraskovsky E; Braley H; Davey GM; Mottram P; van de Velde N; Jensen K; Lew AM; Wright MD; Heath WR; Shortman K; Lahoud MH
    Blood; 2008 Oct; 112(8):3264-73. PubMed ID: 18669894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination.
    Reuter A; Panozza SE; Macri C; Dumont C; Li J; Liu H; Segura E; Vega-Ramos J; Gupta N; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    J Immunol; 2015 Mar; 194(6):2696-705. PubMed ID: 25653426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
    Bonifaz LC; Bonnyay DP; Charalambous A; Darguste DI; Fujii S; Soares H; Brimnes MK; Moltedo B; Moran TM; Steinman RM
    J Exp Med; 2004 Mar; 199(6):815-24. PubMed ID: 15024047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection.
    Torres D; Köhler A; Delbauve S; Caminschi I; Lahoud MH; Shortman K; Flamand V
    PLoS Pathog; 2016 Apr; 12(4):e1005561. PubMed ID: 27074026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing immune responses by targeting antigen to DC.
    Caminschi I; Lahoud MH; Shortman K
    Eur J Immunol; 2009 Apr; 39(4):931-8. PubMed ID: 19197943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.
    Idoyaga J; Cheong C; Suda K; Suda N; Kim JY; Lee H; Park CG; Steinman RM
    J Immunol; 2008 Mar; 180(6):3647-50. PubMed ID: 18322168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
    Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
    Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.
    Tullett KM; Tan PS; Park HY; Schittenhelm RB; Michael N; Li R; Policheni AN; Gruber E; Huang C; Fulcher AJ; Danne JC; Czabotar PE; Wakim LM; Mintern JD; Ramm G; Radford KJ; Caminschi I; O'Keeffe M; Villadangos JA; Wright MD; Blewitt ME; Heath WR; Shortman K; Purcell AW; Nicola NA; Zhang JG; Lahoud MH
    Elife; 2020 Dec; 9():. PubMed ID: 33264090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.
    Price JD; Hotta-Iwamura C; Zhao Y; Beauchamp NM; Tarbell KV
    Diabetes; 2015 Oct; 64(10):3521-31. PubMed ID: 26070317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
    Moulin V; Morgan ME; Eleveld-Trancikova D; Haanen JB; Wielders E; Looman MW; Janssen RA; Figdor CG; Jansen BJ; Adema GJ
    Cancer Gene Ther; 2012 May; 19(5):303-11. PubMed ID: 22361816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.
    Soares H; Waechter H; Glaichenhaus N; Mougneau E; Yagita H; Mizenina O; Dudziak D; Nussenzweig MC; Steinman RM
    J Exp Med; 2007 May; 204(5):1095-106. PubMed ID: 17438065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.